c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line
- PMID: 15027120
- DOI: 10.1002/ijc.20095
c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line
Abstract
Transcription factor c-Jun serves for cellular proliferation, survival, differentiation and transformation and is recognized as an important factor in cancer development, including hepatocellular carcinoma (HCC). The purpose of present study is to determine the involvement of c-Jun in matrix metalloproteinase-1 (MMP-1) expression, which is previously reported by us to be expressed only in the early stage of human HCC showing stromal invasion. Of 5 human HCC cell lines examined, only HLE cells revealed mRNA and protein expression as well as enzymatic activity of MMP-1. Transient transfection of an MMP-1 promoter/luciferase construct (including 4.4 kb full promoter region) into HLE and HCC-T cells (MMP-1 nonproducer) showed that high promoter activity was observed only in HLE cells without inducers, and that this promoter activity was still observed when a shorter 0.6 kb proximal promoter construct was transfected. The 0.6 kb promoter region contained 3 AP-1 sites, and c-jun mRNA was constitutively expressed in HLE cells without inducers. Furthermore, phosphorylated c-Jun and c-Jun NH2-terminal kinase (JNK) were detected in HLE cells. Promoter activity of the 0.6 kb construct was suppressed with SP600125, a potent inhibitor of JNK, but not with PD98059 and SB203580, potent inhibitors of MEK1/2 and p38, respectively. The inhibitory effect of SP600125 was also observed at protein expression level and in enzymatic activity of MMP-1. Taken together, this study suggests that the JNK pathway is involved in the expression of MMP-1 in HCC cells and may represent a new functional role of c-Jun for HCC development.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.Oncogene. 1997 Mar 27;14(12):1481-93. doi: 10.1038/sj.onc.1200973. Oncogene. 1997. PMID: 9136992
-
Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: Association with the invasive potential.Toxicol Lett. 2007 Jun 15;171(1-2):78-86. doi: 10.1016/j.toxlet.2007.04.009. Epub 2007 Apr 27. Toxicol Lett. 2007. PMID: 17543481
-
Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.Toxicol Lett. 2009 Feb 10;184(3):204-10. doi: 10.1016/j.toxlet.2008.11.018. Epub 2008 Dec 6. Toxicol Lett. 2009. PMID: 19110045
-
Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma.Mol Biol Rep. 2016 Feb;43(2):107-16. doi: 10.1007/s11033-016-3943-9. Epub 2016 Jan 14. Mol Biol Rep. 2016. PMID: 26767647 Review.
-
Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.Target Oncol. 2016 Dec;11(6):723-738. doi: 10.1007/s11523-016-0446-5. Target Oncol. 2016. PMID: 27392951 Review.
Cited by
-
Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model.Sci Rep. 2022 Aug 10;12(1):13639. doi: 10.1038/s41598-022-17954-x. Sci Rep. 2022. PMID: 35948625 Free PMC article.
-
M-Ras induces Ral and JNK activation to regulate MEK/ERK-independent gene expression in MCF-7 breast cancer cells.J Cell Biochem. 2012 Apr;113(4):1253-64. doi: 10.1002/jcb.23458. J Cell Biochem. 2012. PMID: 22121046 Free PMC article.
-
Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.Am J Pathol. 2006 Aug;169(2):445-58. doi: 10.2353/ajpath.2006.050676. Am J Pathol. 2006. PMID: 16877347 Free PMC article.
-
Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma.BMC Complement Altern Med. 2014 Apr 30;14:141. doi: 10.1186/1472-6882-14-141. BMC Complement Altern Med. 2014. PMID: 24886639 Free PMC article.
-
The role of cyclooxygenase-2, interleukin-1β and fibroblast growth factor-2 in the activation of matrix metalloproteinase-1 in sheared-chondrocytes and articular cartilage.Sci Rep. 2015 May 20;5:10412. doi: 10.1038/srep10412. Sci Rep. 2015. PMID: 25992485 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous